Alternatives to Supporting the achievement of the objectives of the Council of Europe Convention on preventing and combating violence against women (VAW) and domestic violence in the Union and …

Expected Outcome: Project results are expected to contribute to all of the following expected outcomes: Project promoters, public authorities, and investors have a better understanding of the capital market demand and supply dynamics that underlie investments in projects fostering the transformation of neighbourhoods [1] in line with the New European Bauhaus (NEB). Increased investments towards NEB-aligned projects for the sustainable [1] and inclusive [1] transformation of neighbourhoods. Scope: Increased investment in projects for the transformation of neighbourhoods in line with the New European Bauhaus (NEB) may be hindered due to a discrepancy between the demand and supply of capital in terms of size, diversity, returns, and risk. Small-scale NEB-aligned projects typically encounter large, short-term oriented, and highly risk-averse investment funds, which seek investment opportunities able to absorb large amounts of funding, driven by present legislation [4] . Place-based impact investing is an approach that can contribute to investments in NEB-aligned neighbourhood projects by providing risk-adjusted financial returns while creating local social, cultural, aesthetic [5] and…

Expected Outcome: The general objective of the call is to further develop the social enterprise finance market by supporting the social finance intermediaries to provide the needed capital to social enterprises and mission-driven enterprises. In this direction, the call builds upon previous similar calls and aims above all to support social finance intermediaries who undertake long-term risk capital investments in social enterprises and mission-driven enterprises . Therefore, the key objective of the present call of proposals is to catalyse risk capital investments below EUR 1 000 000 that otherwise would not happen in the area of social enterprise finance. The call aims to support the transaction costs for these low value investment tickets and thus to help to overcome the identified market failure / mismatch in the social investment market . The present call also encourages the European (trans-national) and innovative dimension of social finance schemes and support towards emerging social finance markets, e.g. via cross-border investments and cooperation, dissemination of good practices, etc. Under this call for proposals, the transaction costs support scheme will take the form…

Scope: This award aims to recognise sport activities implemented by organisations working with sport across generations and contributing to strengthen communities. It recognises organisations that have made a significant contribution to strengthening communities promoting inter-generational activities through sport, providing easier access to sport & physical activities for all generations and keeping in mind interests of future generations. This category celebrates initiatives that use sport to bring people of all ages together, fostering intergenerational connections, inclusion, and long-term community development. It highlights the power of sport in bridging generational gaps, fostering understanding, and creating stronger, more connected communities.

Scope: This award aims to recognise sport activities implemented by organisations and/or individuals that have made outstanding contributions to sports through volunteer work. It also recognises dedication, leadership, and the positive impact of volunteers in fostering community engagement, inclusivity, and the development of sports at all levels. This category celebrates organisations and individuals that have demonstrated outstanding commitment to supporting and developing sports through volunteer efforts. It highlights the crucial role volunteers play in shaping the future of sports and inspiring positive change in their communities.

Scope: This topic is one of the 5 priorities of the call for proposals for EU action grants to prevent and combat gender-based violence and violence against children under the Citizens, Equality, Rights and Value Programme (CERV) . For further information about the call and its conditions, please see the call document.

Scope: This topic is one of the 5 priorities of the call for proposals for EU action grants to prevent and combat gender-based violence and violence against children under the Citizens, Equality, Rights and Value Programme (CERV) . For further information about the call and its conditions, please see the call document.

Scope: This topic is one of the 5 policy priorities of the call for proposals for EU action grants to prevent and combat gender-based violence and violence against children under the Citizens, Equality, Rights and Value Programme (CERV) . For further information about the call and its conditions, please see the call document.

Scope: This topic is one of the 5 priorities of the call for proposals for EU action grants to prevent and combat gender-based violence and violence against children under the Citizens, Equality, Rights and Value Programme (CERV) . For further information about the call and its conditions, please see the call document.

Expected Impact: The action under this topic is expected to achieve the following impacts: Faster and more informed decision-making through the use of an AI-driven NAM (AI Foundation Toxicology Model) and increased efficiency through rapid processing of vast amounts of data [1] . Increased consistency and standardisation in a NAM-based approach, specifically an AI model, used by industry in the efficient development, testing and production of safe and effective innovative health technologies, improving industrial competitiveness. Regulatory adoption of a NAM-enabled second species waiver model (AI Foundation Toxicology Model) and weight-of-evidence framework, in line with recommendations and more consistent global decision-making on waiving second species testing. Reduction in animal use, accelerated timelines and lower costs, enhancing the competitiveness of the European health industry through economical and ethical benefits. Improved public health as patients will benefit from safe and effective medicines developed faster using validated NAMs. The action is expected to contribute to the EU Directive (2010/63/EU) [2] on the protection of animals used for scientific purposes and…

Expected Impact: The action under this topic is expected to achieve the following impacts: Accelerate EU access to more cost-effective interventions in an increasingly ageing population by identifying personalised treatment approaches for elderly-onset immune diseases. Decrease disease risk later in life by defining specific prevention strategies based on ageing biomarkers and risk factors. Halt age-associated disease exacerbation by the identification of predictive and digital biomarkers that can stratify patients for early intervention. Improve quality of life for healthy individuals and patients by preventing further health decline, avoiding escalating care costs, and properly stratifying individuals earlier in the diagnostic pathway. Accelerate adoption of innovative diagnostic, preventative, and therapeutic strategies, strengthening the EU’s position as a healthcare innovator. Evaluate digital biomarker as potential regulatory endpoints in the ultimate goal to develop medicines for ‘healthy ageing’. Integrate fragmented research efforts by bringing together health industry sectors and stakeholders to develop clinical and multi-omics data integration capabilities. Enable new…

Expected Impact: The action under this topic is expected to achieve the following impacts and contribute to the following EU policies/initiatives: deliver innovative, early technology solutions that contribute to addressing strategic unmet public health needs across multiple therapy areas to improve prevention, early diagnosis, and treatment; leverage the unique network and scale of IHI JU members to create a pipeline to support innovative startups in the health industry, fully integrated into European initiatives in support of start-ups and entrepreneurship; drive early cross-sector health R&D and innovation to strengthen the European healthcare industry’s global competitiveness, contributing to the EU Industrial Strategy and Pharmaceutical Strategy objectives; create a sustainable network of European healthcare incubators to guide and support highly talented and innovative early-stage companies; harness digital health and data-sharing technologies (e.g., AI and big data) to enable interoperable health solutions, contributing to the European Health Data Space (EHDS) and improved evidence based care;- the action should generate a portfolio of early‑stage companies that have…

Expected Outcome: This action will establish a strategic European initiative to develop scalable, modular, and interoperable photonic quantum computing platforms. Proposals for this topic are expected to address and provide credible solutions to at least two major technical roadblocks currently limiting the advancement of photonic quantum computing such as: The lack of deterministic, high-efficiency photonic entanglement and loss-tolerant architectures suitable for fault-tolerant scaling The absence of a standardised, integrated control stack combining photonic hardware, firmware, and system software with reliable benchmarking across platforms Project results are expected to contribute to the following expected outcomes: By 2028, demonstration of a photonic NISQ processor with ≥100 photonic qubits, integrating deterministic single-photon sources, low-loss waveguides, on-chip detectors, and a firmware stack (scheduler, controller, compiler), validated via hardware-agnostic benchmarks and hybrid photonic-HPC applications demonstrating classical-quantum crossover By 2030, delivery of a full-stack, high-connectivity photonic quantum computer, with modular scalability, integrated…